DNA Brands, Inc. (OTC PINK: DNAX) is pleased to announce that it has signed a Letter of Intent (LOI) to acquire the majority ownership of an Online Medical Resource Company. Its founder, a Medical Doctor of 25 years, will also be joining the DNA Brands management team.
The acquisition candidate's current website offers medical consumers to take control of their own healthcare. It is a resource that provides over 17,000 pages of content, which include medical health articles, blogs, videos, lab testing and natural remedies. This site does this by offering thousands of definitions and hundreds of articles. There are over sixteen thousand, (16,000) different medicinal products for sale on the site. This site will position DNA an immediate dual revenue stream, first from sales of their product line and secondly from advertising sales on the site.
DNA Brands is focusing on ancillary businesses related to Medical Marijuana/ Cannabinoid (CBD)/ Industrial Hemp Markets. DNA Brands and its majority shareholders (who stand behind and support the company), believe that this online medical resource company will create a great platform to go hand in hand with medical marijuana related products and subject matters.
As previously mentioned, DNA Brands intends to focus company efforts both online and physically. Concentrating in the North and Southeastern States, as they are in their Infancy of the Medical Marijuana/ CBD and Industrial Hemp space.
In other news, on June 23rd, 2017, Governor Rick Scott of Florida (FL) signed into law the state's own Medical Marijuana Laws.
According to the Orlando Sentinel: "Florida patients with certain debilitating diseases will have access to medical marijuana under a bill signed into law by Gov. Rick Scott on Friday, June 23rd.
The legislation formalizes an amendment to the state constitution approved by 71 percent of voters last fall that legalized medical marijuana, and sets up regulations for the new industry.
Scott, who voted against the amendment, did not issue a statement upon signing the bill. He had earlier stated he would sign the bill.
Patients with cancer, epilepsy, glaucoma, HIV/AIDS, post-traumatic stress disorder, multiple sclerosis, Parkinson's disease or other debilitating conditions are eligible to be prescribed cannabis products by a doctor."
